Coagulation factor levels in solvent/detergent-treated plasma.
نویسندگان
چکیده
Recently, an extensive committee report on the current status of solvent/detergent (S/D)-treated frozen plasma was published by Klein et al.1 in TRANSFUSION. Although S/Dtreated plasma is now widely used, little is published about the amount and the stability of the individual coagulation factors in S/D-treated plasma.2,3 According to the manufacturers, S/D treatment does not significantly alter the concentration of coagulation factors, and a concentration of the individual coagulation factors of at least >0.50 U per mL (50% of normal) is guaranteed. Although this level is above the hemostatic value of most coagulation factors, it may be insufficient for correction of severe deficiencies of coagulation factors. We studied the levels of several coagulation factors in seven batches of S/D-treated plasma (ESDEP, CLB, Amsterdam, the Netherlands). This S/D-treated plasma is prepared from pooled fresh-frozen plasma (FFP) from healthy unpaid Dutch blood donors. The technology used to prepare S/D-treated plasma was developed by Octopharma AG (Glarus, Switzerland).4 S/D-treated plasma was thawed in a waterbath at 37oC for 20 minutes according to the manufacturer’s instructions. Plasma samples were tested in duplicate immediately after thawing and after storage at room temperature for 2, 4, and 8 hours. Antithrombin, plasminogen, and antiplasmin were measured wtih chromogenic assays. Other coagulation factors, including protein S and protein C activity; factors II, V, VII, VIII, IX, X, XI, and XII; and fibrinogen, were determined according to standard clotting assay procedures. Protein C, protein S, and von Willebrand factor (vWF) antigen levels, as well as binding of vWF to collagen were determined by enzyme-linked immunosorbent assays. For our laboratory assays, reference pooled plasma was obtained from 40 healthy volunteers. Coagulation factors were not determined in FFP before S/D treatment. The results of the concentrations and activities of coagulation factors in S/D-treated plasma are shown in Table 1. Most coagulation factors are present at a level that is found in normal pooled plasma. However, antiplasmin and protein S activities are decreased to less than 50 percent of those in normal pooled plasma. All coagulation factors were stable at room temperature for at least 8 hours, except protein S activity, which decreased from a median of 0.45 U per mL (range, 0.42-0.53) to one of 0.34 U per mL (0.29-0.36). The low levels of antiplasmin and protein S activity in S/D-treated plasma may be of clinical importance. Besides being low in patients with a congenital antiplasmin deficiency, the levels of antiplasmin can be greatly decreased in patients with severe liver disease, after thrombolytic therapy, during liver transplantation, in patients with amyloidosis, and in patients with acute promyelocytic leukemia.5,6 In these patients, the infusion of S/D-treated plasma may be insufficient to correct the antiplasmin deficiency. It is known that levels of 50 percent, as are found in patients who are heterozygous for antiplasmin deficiency, may be associated with a mild hemorrhagic tendency.5 Therefore, in case of severe antiplasmin deficiency, FFP instead of S/ D-treated plasma may be required to achieve an antiplasmin level >50 percent of normal. The importance of the low levels of protein S is less clear. Hereditary protein S deficiency is associated with a thrombotic tendency. In patients with purpura fulminans caused by bacterial or viral infections, reduced levels of protein C and protein S have been reported.7 Because these patients are nearly always treated with plasma substitution, the concentration of proteins S and C in the infused plasma may be of importance. Theoretically, the infusion of plasma that is deficient in protein S may be less effective in this patient group than the infusion of FFP. All other coagulation factors that we measured, including vWF, were present at normal levels when compared to the levels in normal pooled plasma. Earlier studies indi-
منابع مشابه
Fibrinolysis during liver transplantation is enhanced by using solvent/detergent virus-inactivated plasma (ESDEP).
UNLABELLED After the introduction of solvent/detergent-treated plasma (ESDEP) in our hospital, an increased incidence of hyperfibrinolysis was observed (75% vs 29%; P = 0.005) compared with the use of fresh frozen plasma for liver transplantation. To clarify this increased incidence, intraoperative plasma samples of patients treated with fresh frozen plasma or ESDEP were analyzed in a retrospec...
متن کاملSolvent/detergent plasma for prevention of bleeding in recessively inherited coagulation disorders: dosing, pharmacokinetics and clinical efficacy.
BACKGROUND AND OBJECTIVES This open-label multicenter trial of solvent/detergent (SD) plasma involving 17 patients with recessively inherited coagulation disorders (one afibrinogenemia, four FV, six combined FV and FVIII, one FX and five FXI deficiencies) evaluated the pharmacokinetics of the deficient factors and hemostatic efficacy. DESIGN AND METHODS In vivo recovery (IVR) of the deficient...
متن کاملPreparation of factor VII concentrate using CNBr-activated
Background: Factor VII concentrates are used in patients with congenital or acquired factor VII deficiency or treatment of hemophilia patients with inhibitors. In this research, immunoaffinity chromatography was used to purify factor VII from prothrombin complex (Prothrombin-Proconvertin-Stuart Factor-Antihemophilic Factor B or PPSB) which contains coagulation factors II, VII, IX and X. The a...
متن کاملA STUDY ON THE APPLICATION AND EFFICACY OF SOLVENT-DETERGENT (SID) TREATMENT IN THE PROCESS OF PURIFYING FACTOR VII FROM PROTHROMBIN COMPLEX
The risks of transmitting viral infection by blood and plasma-derived products have long been known and still remain an area of concern. In this study, in the process of purifying human factor VII from prothrombin complex, SID treatment using tri-n-butyl phosphate and Tween 80 was employed and its capability and efficacy was studied. The results indicated that the process did not affect th...
متن کاملRelative concentrations of haemostatic factors and cytokines in solvent/detergent-treated and fresh-frozen plasma.
BACKGROUND Indications, efficacy, and safety of plasma products are highly debated. We compared the concentrations of haemostatic proteins and cytokines in solvent/detergent-treated plasma (SDP) and fresh-frozen plasma (FFP). METHODS Concentrations of the following parameters were measured in 25 SDP and FFP samples: fibrinogen (FBG), factor (F) II, F V, F VII, F VIII, F IX, F X, F XIII, von W...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Transfusion
دوره 39 10 شماره
صفحات -
تاریخ انتشار 1999